581 related articles for article (PubMed ID: 21615386)
1. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
2. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids and response to chemotherapy.
Dimanche-Boitrel MT; Rebillard A
Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
[TBL] [Abstract][Full Text] [Related]
5. Novel chemotherapeutic drugs in sphingolipid cancer research.
Canals D; Hannun YA
Handb Exp Pharmacol; 2013; (215):211-38. PubMed ID: 23579458
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipid metabolism and neutral sphingomyelinases.
Airola MV; Hannun YA
Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid modulation: a strategy for cancer therapy.
Delgado A; Fabrias G; Bedia C; Casas J; Abad JL
Anticancer Agents Med Chem; 2012 May; 12(4):285-302. PubMed ID: 21864240
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of Ceramidases.
Saied EM; Arenz C
Chem Phys Lipids; 2016 May; 197():60-8. PubMed ID: 26220616
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
10. Increase in sphingolipid catabolic enzyme activity during aging.
Sacket SJ; Chung HY; Okajima F; Im DS
Acta Pharmacol Sin; 2009 Oct; 30(10):1454-61. PubMed ID: 19749786
[TBL] [Abstract][Full Text] [Related]
11. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.
Parveen F; Bender D; Law SH; Mishra VK; Chen CC; Ke LY
Cells; 2019 Dec; 8(12):. PubMed ID: 31817238
[TBL] [Abstract][Full Text] [Related]
12. Novel drugs targeting sphingolipid metabolism.
Bhabak KP; Arenz C
Handb Exp Pharmacol; 2013; (215):187-96. PubMed ID: 23579456
[TBL] [Abstract][Full Text] [Related]
13. Medicinal chemistry aspects of drug targets in sphingolipid metabolism.
Nussbaumer P
ChemMedChem; 2008 Apr; 3(4):543-51. PubMed ID: 18061920
[No Abstract] [Full Text] [Related]
14. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
15. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
Yu Z; Peng Q; Huang Y
Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
[TBL] [Abstract][Full Text] [Related]
17. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid metabolism in the regulation of bioactive molecules.
Luberto C; Hannun YA
Lipids; 1999; 34 Suppl():S5-11. PubMed ID: 10419081
[No Abstract] [Full Text] [Related]
19. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
Di Pietro P; Izzo C; Abate AC; Iesu P; Rusciano MR; Venturini E; Visco V; Sommella E; Ciccarelli M; Carrizzo A; Vecchione C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671552
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of sphingolipid metabolism enzymes.
Delgado A; Casas J; Llebaria A; Abad JL; Fabrias G
Biochim Biophys Acta; 2006 Dec; 1758(12):1957-77. PubMed ID: 17049336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
